Interferon beta-1a (interferon beta-1a)

Approved for AVONEX is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.. The mechanism of action by which AVONEX exerts its effects in patients with multiple sclerosis is unknown. Side effects, costs, interactions, manufacturer, and generic…

Loading full data from Know Your Drugs Institute…